SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 IN A DOSE ESCALATING REGIMEN IN PATIENTS WITH METASTATIC RENAL-CELL ADENOCARCINOMA

被引：0
|
作者：
WHITEHEAD, RP
WARD, D
HEMINGWAY, L
HEMSTREET, GP
BRADLEY, E
KONRAD, M
机构：
[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT MED,OKLAHOMA CITY,OK 73190
[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT UROL,OKLAHOMA CITY,OK 73190
[3] CETUS CORP,EMERYVILLE,CA 94608
来源：
CANCER RESEARCH | 1990年 / 50卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6708 / 6715
页数：8
相关论文
共 50 条
  • [21] IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 (LOW-DOSE) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    MARUMO, K
    MURAKI, J
    UENO, M
    TACHIBANA, M
    DEGUCHI, N
    BABA, S
    JITSUKAWA, S
    HATA, M
    TAZAKI, H
    UROLOGY, 1989, 33 (03) : 219 - 225
  • [22] PROGNOSTIC FACTORS OF THE CLINICAL-RESPONSE TO SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 ALONE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    LISSONI, P
    BARNI, S
    ARDIZZOIA, A
    CRISPINO, S
    PAOLOROSSI, F
    ANDRES, M
    SCARDINO, E
    TANCINI, G
    ONCOLOGY, 1994, 51 (01) : 59 - 62
  • [23] Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma
    Negrier, S
    Escudier, B
    Lasset, C
    Douillard, JY
    Savary, J
    Chevreau, C
    Ravaud, A
    Mercatello, A
    Peny, J
    Mousseau, M
    Philip, T
    Tursz, T
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18): : 1272 - 1278
  • [24] IMMUNOTHERAPY OF ADVANCED RENAL-CELL CANCER USING SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA
    KIRCHNER, H
    DERIESE, W
    ALLHOFF, E
    POLIWODA, H
    ATZPODIEN, J
    WORLD JOURNAL OF UROLOGY, 1991, 9 (04) : 219 - 222
  • [25] A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA
    VUORISTO, M
    JANTUNEN, I
    PYRHONEN, S
    MUHONEN, T
    KELLOKUMPULEHTINEN, P
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (04) : 530 - 532
  • [26] CONTINUOUS INTRAVENOUS INTERLEUKIN-2 INFUSION AND SUBCUTANEOUS INTERFERON-ALPHA IN METASTATIC RENAL-CELL CARCINOMA
    FOSSA, SD
    AUNE, H
    BAGGERUD, E
    GRANERUD, T
    HEILO, A
    THEODORSEN, L
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) : 1313 - 1315
  • [27] IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    MARUMO, K
    MURAKI, J
    UENO, M
    DEGUCHI, N
    BABA, S
    TAZAKI, H
    JOURNAL OF UROLOGY, 1987, 137 (04): : A146 - A146
  • [28] THE EFFECTS OF ORAL PENTOXIFYLLINE ON INTERLEUKIN-2 TOXICITY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    ANDERSON, JA
    WOODCOCK, TM
    HARTY, JI
    KNOTT, AW
    EDWARDS, MJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 714 - 717
  • [29] RECOMBINANT INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA - A EUROPEAN MULTICENTER PHASE-II STUDY
    VONDERMAASE, H
    GEERTSEN, P
    THATCHER, N
    JASMIN, C
    MERCATELLO, A
    FOSSA, SD
    SYMANN, M
    STOTER, G
    NAGEL, G
    ISRAEL, L
    OSKAM, R
    PALMER, P
    FRANKS, CR
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1583 - 1589
  • [30] Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
    McDermott, DF
    Regan, MM
    Clark, JI
    Flaherty, LE
    Weiss, GR
    Logan, TF
    Kirkwood, JM
    Gordon, MS
    Sosman, JA
    Ernstoff, MS
    Tretter, CPG
    Urba, WJ
    Smith, JW
    Margolin, KA
    Mier, JW
    Gollob, JA
    Dutcher, JP
    Atkins, MB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 133 - 141
12345